These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 23138014)

  • 21. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
    Tendera M; Borer JS; Tardif JC
    Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
    Shavarov AA; Kiiakbaev GK; Kobalava ZhD
    Ter Arkh; 2013; 85(4):77-83. PubMed ID: 23808298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.
    Zarifis J; Grammatikou V; Kallistratos M; Katsivas A;
    Clin Cardiol; 2015 Dec; 38(12):725-32. PubMed ID: 26782939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS; Tardif JC
    Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The comparative effectiveness of beta-blockers and inhibitors of if-iodium using in patients with stable angina pectoris].
    Shirokova S; Ilashchuk T; Okipniak I
    Georgian Med News; 2015 Mar; (240):25-8. PubMed ID: 25879554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients.
    Nerla R; Di Franco A; Milo M; Pitocco D; Zaccardi F; Tarzia P; Sarullo FM; Villano A; Russo G; Stazi A; Ghirlanda G; Lanza GA; Crea F
    Heart; 2012 Dec; 98(24):1812-6. PubMed ID: 23086971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of resting heart rate with antianginal drugs: review and meta-analysis.
    Cucherat M; Borer JS
    Am J Ther; 2012 Jul; 19(4):269-80. PubMed ID: 21804377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy.
    Jiang J; Cong H; Zhang Y; Li Z; Tao G; Li X; Qing L; Tan N; Zhao Z; Dong Y; Ji Z; Chen Y; Ge J; He B; Sun Y; Cao K; Huo Y
    Int J Med Sci; 2017; 14(5):477-483. PubMed ID: 28539824
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study].
    Glezer MG; Saĭgitov RT
    Kardiologiia; 2010; 50(11):65-75. PubMed ID: 21526568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
    Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivabradine in stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
    Danchin N; Marzilli M; Parkhomenko A; Ribeiro JP
    Cardiology; 2011; 120(2):59-72. PubMed ID: 22122948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L; Filipova S; Martos R
    Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New opportunities to improve the treatment effectiveness of patients with stable angina].
    Grigoryeva NY; Vilkova OE; Samolyuk MO; Kolosova KS
    Kardiologiia; 2020 Jul; 60(6):1135. PubMed ID: 32720615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
    Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
    Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.